CVD Equipment (CVV) 10-K 31 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 13, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	CVD EQUIPMENT CORP
Document Type	10-K
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		6,169,477
Entity Public Float			$61,986,440
Amendment Flag	FALSE
Entity Central Index Key	766792
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current Assets
Cash and cash equivalents	$11,966,863	$11,247,560
Accounts receivable, net	6,463,050	2,883,443
Costs and estimated earnings in excess of billings on uncompleted contracts	2,498,662	1,577,969
Inventories, net	4,842,059	4,497,349
Deferred income taxes	2,887,960	1,443,321
Other current assets	194,756	246,240
Total Current Assets	28,853,350	21,895,882
Property, plant and equipment, net	15,025,283	15,492,111
Construction in progress	389,276	128,171
Deferred income taxes	750,133	710,983
Restricted Cash	400,000	800,000
Other assets	82,559	70,376
Intangible assets, net	55,871	44,116
Total Assets	45,556,472	39,141,639
Current Liabilities
Accounts payable	1,682,838	468,072
Accrued expenses	3,297,052	1,806,370
Current maturities of long-term debt	720,000	720,000
Billings in excess of costs and estimated earnings on uncompleted contracts	1,328,508	252,890
Deferred revenue	488,691	204,527
Accrued loss on litigation settlement	4,925,000
Total Current Liabilities	12,442,089	3,451,859
Long-term debt, net of current portion	3,845,508	4,565,508
Total Liabilities	16,287,597	8,017,367
Commitments and Contingencies (Note 16)
Common stock - $0.01 par value – 10,000,000 shares authorized: issued and outstanding, 6,162,027 shares at December 31, 2014 and 6,091,707 shares at December 31, 2013	61,620	60,917
Additional paid-in capital	22,144,805	21,527,375
Retained earnings	7,062,450	9,535,980
Total Stockholders’ Equity	29,268,875	31,124,272
Total Liabilities and Stockholders’ Equity	$45,556,472	$39,141,639

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Common stock, par value (in Dollars per share)	$0.01	$0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	6,162,027	6,091,707
Common stock, shares outstanding	6,162,027	6,091,707

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenue	$27,990,463	$17,883,927
Cost of revenue	16,465,084	11,173,893
Gross profit	11,525,379	6,710,034
Operating expenses
Research and development	877,788	1,013,157
Selling and shipping	1,282,101	1,027,296
General and administrative	8,204,514	6,076,783
Loss on litigation settlement	4,925,000
Bad debt expense		1,281,352
(Gain) on sale of buildings		-887,477
Total operating expenses	15,289,403	8,516,111
Operating (loss)	-3,764,024	-1,806,077
Other income (expense):
Interest income	33,159	29,931
Interest expense	-109,418	-163,738
Other income/(expense)	130,813	-16,846
Total other income/(expense) net	54,554	-150,653
(Loss) before income tax expense	-3,709,470	-1,956,730
Income tax (benefit)	-1,235,940	-1,396,407
Net (loss)	($2,473,530)	($560,323)
Basic (loss) per common share (in Dollars per share)	($0.40)	($0.09)
Diluted (loss) per common share (in Dollars per share)	($0.40)	($0.09)
Outstanding-basic (in Shares)	6,129,831	6,071,375
Outstanding-diluted (in Shares)	6,129,831	6,071,375

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Stockholders' Equity (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2012	$60,470	$20,990,891	$10,096,303	$31,147,664
Balance (in Shares) at Dec. 31, 2012	6,046,970
Exercise of stock options	167	75,569		75,736
Exercise of stock options (in Shares)	16,650			16,650
Stock-based compensation	280	460,915		461,195
Stock-based compensation (in Shares)	28,087
Net (loss)			-560,323	-560,323
Balance at Dec. 31, 2013	60,917	21,527,375	9,535,980	31,124,272
Balance (in Shares) at Dec. 31, 2013	6,091,707			6,091,707
Exercise of stock options	280	101,920		102,200
Exercise of stock options (in Shares)	28,000			28,000
Stock-based compensation	423	515,510		515,933
Stock-based compensation (in Shares)	42,320
Net (loss)			-2,473,530	-2,473,530
Balance at Dec. 31, 2014	$61,620	$22,144,805	$7,062,450	$29,268,875
Balance (in Shares) at Dec. 31, 2014	6,162,027			6,162,027

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Cash flows from operating activities:
Net (loss)	($2,473,530)		($560,323)
Stock-based compensation	515,933		461,195
(Gain) on sale of buildings			-887,477
(Gain)/loss on sale of other fixed assets	-8,000		16,575
Depreciation and amortization	797,928	[1]	646,422	[1]
Deferred income tax benefit	-1,483,789		-1,396,407
Provision for doubtful accounts	-58,007		75,071
Accounts receivable	-3,521,600		1,556,610
Cost in excess of billings on uncompleted contracts	-920,693		1,152,135
Inventories, net	-344,709		-1,754,444
Other current assets	51,484		-53,801
Accounts payable	1,214,766		-419,986
Accrued expenses	1,490,682		450,982
Billings in excess of costs and estimated earnings on uncompleted contracts	1,075,618		-223,015
Accrued loss on litigation settlement	4,925,000
Deferred revenue	284,164		-130,877
Total adjustments	4,018,777		-507,017
Net cash provided by/(used in) operating activities	1,545,247		-1,067,340
Cash flows from investing activities:
Restricted cash	400,000
Capital expenditures	-617,761		-2,071,557
Proceeds from sale of building			3,619,899
Proceeds from sale of other fixed assets	8,000
Deposits	1,617		6,833
Net cash (used in)/provided by investing activities	-208,144		1,555,175
Cash flows from financing activities
Net proceeds from stock options exercised	102,200		75,735
Payments of long-term debt	-720,000		-3,037,334
Net cash (used in) financing activities	-617,800		-2,961,599
Net increase/(decrease) in cash and cash equivalents	719,303		-2,473,764
Cash and cash equivalents at beginning of year	11,247,560		13,721,324
Cash and cash equivalents at end of year	11,966,863		11,247,560
Income taxes paid	0		25
Interest paid	$109,418		$163,738
[1]	Includes amortization expense of $20,007 and $20,434 for the years ending December 31, 2014 and 2013, respectively. Such amortization expense relates to other capitalized and intangible assets.

Note_1_Business_Description

Note 1 - Business Description	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Business Description and Basis of Presentation [Text Block]	Note 1 – Business Description
	CVD Equipment Corporation and its subsidiaries (the “Company”), a New York corporation, was organized and commenced operations in October 1982. Its principal business activities include the manufacturing of chemical vapor deposition equipment, customized gas control systems, the manufacturing of process equipment suitable for the synthesis of a variety of one-dimensional nanostructures and nanomaterials and a line of furnaces, all of which are used primarily to produce semiconductors and other electronic components. The Company engages in business throughout the United States and internationally.

Note_2_Summary_of_Significant_

Note 2 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 2 - Summary of Significant Accounting Policies
	Principles of Consolidation
	The consolidated financial statements include the accounts of CVD Equipment Corporation and its wholly owned subsidiaries. In December 1998, a subsidiary, Stainless Design Concepts, Ltd., was formed as a New York Corporation. In April 1999, this subsidiary was merged into CVD Equipment Corporation. The Company has two wholly owned subsidiaries: CVD Materials Corporation, which provides marketing for our Application Laboratory and FAE Holdings 411519R, LLC, a real estate holding company whose sole asset is its interest in the real estate and building housing our corporate headquarters. All significant intercompany accounts and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	The Company’s significant estimates are the accounting for certain items such as revenues on long-term contracts recognized on the percentage-of-completion method, depreciation and amortization, valuation allowances for deferred tax assets, impairment considerations of long-lived assets and stock-based compensation.
	Revenue Recognition
	Product and service sales, including those based on time and materials type contracts, are recognized when persuasive evidence of an arrangement exists, product delivery has occurred or services have been rendered, pricing is fixed or determinable, and collection is reasonably assured. Service sales, principally representing repair, maintenance and engineering activities are recognized over the contractual period or as services are rendered.
	Revenues from fixed price contracts are recognized on the percentage of completion method, measured on the basis of incurred costs to estimated total costs for each contract. This “cost to cost” method is used because management considers it to be the best available measure of progress on these contracts.
	Contract costs include all direct material and labor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and depreciation costs.
	Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, and final contract settlements may result in revisions to costs and income and are recognized in the period in which the revisions are determined.
	The asset “Costs and estimated earnings in excess of billings on contracts in progress” represents gross revenues recognized in excess of amounts billed.
	The liability “Billing in excess of costs and estimated earnings on contracts in progress” represents gross amounts billed in excess of revenues recognized.
	Inventories
	Inventories are valued at the lower of cost (determined on the first-in, first-out method) or market.
	Income Taxes
	Deferred tax assets and liabilities are determined based on the estimated future tax effects of temporary differences between the financial statements and tax bases of assets and liabilities, as measured by using the future enacted tax rates. Deferred tax expense (benefit) is the result of changes in the deferred tax assets and liabilities. The Company records a valuation allowance against deferred tax assets when it is more likely than not that future tax benefits will not be utilized based on a lack of sufficient positive evidence.
	Investment tax credits are accounted for by the flow-through method, reducing income taxes currently payable and the provision for income taxes in the period the assets giving rise to such credits are placed in service. To the extent such credits are not currently utilized on the Company’s tax return, deferred tax assets, subject to considerations about the need for a valuation allowance, are recognized for the carryforward amount.
	The Company recognizes the tax benefit from an uncertain tax position only if it is more-likely-than-not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The accounting guidance on accounting for uncertainty in income taxes also addresses derecognition, classification, interest and penalties on income taxes, and accounting in interim periods. The Company does not believe it has any uncertain tax positions through the year ending December 31, 2014 which would have a material impact on the Company’s consolidated financial statements.
	The Company and its subsidiaries file combined income tax returns in the U.S. Federal and New York State jurisdiction. In addition, the parent company files standalone tax returns in California, Michigan, Minnesota, New Hampshire and Wisconsin. The Company is no longer subject to U.S. federal and state income tax examinations for tax periods before 2011.
	The Company recognizes interest and penalties accrued related to unrecognized tax benefits, if any, in its income tax provision. The Company had no interest and penalties accrued at December 31, 2014 and 2013.
	Long Lived Assets
	Long-lived assets consist primarily of property, plant and equipment. Long-lived assets are reviewed for impairment whenever events or circumstances indicate their carrying value may not be recoverable. When such events or circumstances arise, an estimate of the future undiscounted cash flows produced by the asset, or the appropriate grouping of assets, is compared to the asset’s carrying value to determine if impairment exists pursuant to the requirements of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 360-10-35, “Impairment or Disposal of Long-Lived Assets.” If the asset is determined to be impaired, the impairment loss is measured on the excess of its carrying value over its fair value. Assets to be disposed of are reported at the lower of their carrying value or net realizable value. The Company had no recorded impairment charges in the consolidated statement of operations during each of the years ended December 31, 2014 and 2013.
	Construction in Progress
	Construction in progress consists of amounts expended for renovating the new facility which was purchased on March 15, 2012. Expenditures for maintenance and repairs are charged to operations as incurred; additions, renewals and betterments are capitalized.
	Computer Software
	The Company follows ASC 350-40, “Internal Use Software.” This standard requires certain direct development costs associated with internal-use software to be capitalized including external direct costs of material and services and payroll costs for employees devoting time to the software projects. These costs totaled $25,185 and $10,890 for the years ended December 31, 2014 and 2013, respectively, and are included in Other Assets. All computer software is amortized using the straight-line method over its estimated useful life of three to five years. Amortization expense related to computer software totaled $11,386 and $7,433 for the years ended December 31, 2014 and 2013, respectively.
	Intangible Assets
	The cost of intangible assets is being amortized on a straight-line basis over their estimated useful lives ranging from 5 to 20 years. Amortization expense recorded by the Company in 2014 and 2013 totaled $20,007 and $6,964, respectively.
	Research & Development
	Research and development costs are expensed as incurred. With our efforts having been utilized exclusively on customer orders, it has historically been included as part of cost of revenue in the consolidated statements of operations. In 2012 we expanded our laboratory staff and began conducting research and development independently. In 2014 we incurred approximately $1,555,000 of research and development expenses of which $878,000 were independent of external customer orders compared to 2013, when we incurred approximately $1,837,000 of research and development expenses of which approximately $1,013,000 were independent of external customer orders.
	Accounts Receivable
	Accounts receivable is presented net of an allowance for doubtful accounts of $24,165 and $107,496 as of December 31, 2014 and 2013, respectively. The allowance is based on historical experience and management’s evaluation of the collectability of accounts receivable. Management believes the allowance is adequate. However, future estimates may fluctuate based on changes in economic and customer conditions. The Company doesn’t require collateral from its customers.
	Product Warranty
	The Company records warranty costs as incurred and does not provide for possible future costs. Management estimates such costs are immaterial, based on historical experience. However, it is reasonably possible that this estimate may differ in future periods.
	Earnings Per Share
	Basic net earnings per common share is computed by dividing the net income by the weighted average number of shares of common stock outstanding during each period. When applicable, diluted earnings per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be adjusted upon exercise of common stock options and warrants.
	Potential common shares issued are calculated using the treasury stock method, which recognizes the use of proceeds that could be obtained upon the exercise of options and warrants in computing diluted earnings per share. It assumes that any proceeds would be used to purchase common stock at the average market price of the common stock during the period.
	Cash and Cash Equivalents
	The Company considers all highly liquid financial instruments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents.
	Concentration of Credit Risk
	Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company places its cash equivalents with high credit-quality financial institutions and invests its excess cash primarily in money market instruments. The Company has established guidelines relative to credit ratings and maturities that seek to maintain stability and liquidity. The Company sells products and services to various companies across several industries in the ordinary course of business. The Company routinely assesses the financial strength of its customers and maintains allowances for anticipated losses based upon historical experience.
	Fair value of Financial Instruments
	The carrying amounts of financial instruments including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, and customer deposits approximate fair value due to the relatively short term maturity of these instruments. The carrying value of long-term debt approximates fair value based on prevailing borrowing rates currently available for loans with similar terms and maturities.
	Stock-Based Compensation
	The Company records stock-based compensation in accordance with the provisions set forth in ASC 718, “Stock Compensation” using the modified prospective method. ASC 718 requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant date fair value of those awards.
	Shipping and Handling
	It is the Company’s policy to include freight charges billed to customers in total revenue. The amount included in revenue was $34,534 and $71,179 for the years ended December 31, 2014 and 2013, respectively. Included in selling and shipping expense is $23,358, and $49,232 for shipping and handling costs for each of the years ended 2014 and 2013, respectively.
	Note 2 - Summary of Significant Accounting Policies (continued)
	Recently Adopted Accounting Pronouncements
	In July 2013, the FASB issued Accounting Standards Update (“ASU”) 2013-10, Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes. The amendments in this Update permit the Fed Funds Effective Swap Rate to be used as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815, in addition to the US Treasury rate and the London Interbank Offered Rate (“LIBOR”). The amendments also remove the restriction on using different benchmark rates for similar hedges. The amendments are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. This ASU is not expected to have a significant impact on the Company’s financial statements.
	In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists. This ASU applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. An unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. For nonpublic entities, the amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. Early adoption is permitted. This ASU is not expected to have a significant impact on the Company’s financial statements.
	We believe there is no additional new accounting guidance adopted, but not yet effective that is relevant to the readers of our financial statements. However, there are numerous new proposals under development which, if and when enacted, may have a significant impact on our financial reporting.

Note_3_Contracts_in_Progress

Note 3 - Contracts in Progress	12 Months Ended
	Dec. 31, 2014
Contractors [Abstract]
Long-term Contracts or Programs Disclosure [Text Block]	Note 3 – Contracts in Progress
	Costs and estimated earnings in excess of billings on percentage of completion type contracts in progress are summarized as follows:
		2014			2013
	Costs incurred on contracts in progress	$	4,250,299		$	1,807,628
	Estimated earnings		4,541,377			1,229,038
			8,791,677			3,036,666
	Billings to date		(7,621,523	)		(1,711,587	)
		$	1,170,154		$	1,325,079
		2014			2013
	Included in accompanying balance sheets
	Under the following captions:
	Costs and estimated earnings in excess of billings on contracts in progress	$	2,498,662		$	1,577,969
	Billings in excess of costs and estimated earnings on contracts in progress	$	(1,328,508	)	$	(252,890	)

Note_4_Inventories

Note 4 - Inventories	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	Note 4 - Inventories
	Inventories consist of:
		2014		2013
	Raw materials	$	4,307,913	$	4,058,350
	Work-in-process		419,731		300,460
	Finished goods		114,415		138,539
	Totals	$	4,842,059	$	4,497,349

Note_5_Property_Plant_and_Equi

Note 5 - Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	Note 5 – Property, Plant and Equipment
	Major classes of property, plant and equipment consist of the following:
			2014			2013
	Land		$	2,220,000		$	2,220,000
	Buildings			6,631,039			6,631,039
	Building improvements			5,577,248			5,417,620
	Machinery and equipment			2,333,129			2,329,299
	Furniture and fixtures			712,549			703,999
	Computer equipment			636,819			576,111
	Transportation equipment			65,994			65,994
	Lab equipment			1,564,082			1,560,251
	Totals at cost			19,740,860			19,504,313
	Less: Accumulated depreciation and amortization			(4,715,577	)		(4,012,202	)
			$	15,025,283		$	15,492,111
	Depreciation and amortization expense (1)		$	797,928		$	646,422
		-1	Includes amortization expense of $20,007 and $20,434 for the years ending December 31, 2014 and 2013, respectively. Such amortization expense relates to other capitalized and intangible assets.

Note_6_Intangible_Assets

Note 6 - Intangible Assets	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	Note 6 – Intangible Assets
	2014
	Intangible Assets	Weighted Average Amortization Period		Cost		Accumulated Amortization		Carrying Amount
	Patents & Copyrights		17	$	77,357	$	33,153	$	44,204
	Intellectual Property		15		100,000		88,333		11,667
	Licensing Agreement		5		10,000		10,000		0
	Certifications		3		58,722		58,722		0
	Other		5		21,492		21,492		0
	Totals			$	267,571	$	211,700	$	55,871
	2013
	Intangible Assets	Weighted Average Amortization Period		Cost		Accumulated Amortization		Carrying Amount
	Patents & Copyrights		17	$	57,818	$	30,369	$	27,449
	Intellectual Property		15		100,000		83,333		16,667
	Licensing Agreement		5		10,000		10,000		0
	Certifications		3		58,722		58,722		0
	Other		5		21,492		21,492		0
	Totals			$	248,032	$	203,916	$	44,116
	The estimated amortization expense related to intangible assets for each of the five succeeding fiscal years and thereafter as of December 31, 2014 is as follows:
	Year Ended
	2015	$	8,084
	2016		8,018
	2017		4,580
	2018		2,915
	2019		2,869
	Thereafter		29,405
	Total	$	55,871

Note_7_Financing_Arrangements

Note 7 - Financing Arrangements	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Short-term Debt [Text Block]	Note 7 – Financing Arrangements
	On August 5, 2014, the Company extended until August 5, 2015, under the same terms, its existing revolving credit facility with HSBC Bank, USA, N.A. (“HSBC”), which was due to expire. The original loan agreement with HSBC was entered into on August 5, 2011, and provided the Company with credit up to $9.1 million. This loan agreement consists of a $7 million revolving credit facility and a five (5) year term loan in the initial principal amount of $2.1 million. The obligations under the loan agreement are secured by substantially all of the Company’s personal property. Additionally, borrowings under the term loan were initially collateralized by $1 million of restricted cash deposits, provided that, so long as no event of default has occurred and then continuing, HSBC would release $200,000 of the collateral on each anniversary of the closing date. The restricted balance at December 31, 2014 was $400,000. This restricted cash is a separate line item on the consolidated balance sheet. The Company makes monthly principal payments of $35,000 plus interest on the term loan which matures on August 1, 2016. The balances as of December 31, 2014 and December 31, 2013 were $700,000 and $1,120,000 respectively. Interest on the unpaid $700,000 principal balance on this facility accrues at either (i) the London Interbank Offered Rate (“LIBOR”) plus 1.75% or (ii) the bank’s prime rate minus 0.50%. The credit agreement also contains certain financial covenants. As of December 31, 2014, we were compliance with the terms of the covenants.
	In March 2012, the Company entered into a mortgage loan agreement with HSBC for the initial principal amount of $6,000,000 (the “Loan”), through the town of Islip Industrial Development Agency. The Loan is secured by a mortgage against the property and building located at 355 South Technology Drive, Central Islip, New York. Interest presently accrues on the Loan, at our option, at the variable rate of LIBOR plus 1.75% which was 1.9108% and 1.9166% at December 31, 2014 and 2013 respectively. The balance on the mortgage at December 31, 2014 was $3,865,508. The Company makes monthly principal payments of $25,000 plus interest on the Loan which matures on March 15, 2022.

Note_8_Longterm_Debt

Note 8 - Long-term Debt	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Long-term Debt [Text Block]	Long-term debt as of December 31 consists of the following:
		2014		2013
	HSBC
	$2,100,000 5 year term loan payable in monthly installments of $35,000 plus interest on the unpaid principal balance which accrues at a fixed rate of 3.045%. This term loan was secured by $1 million, provided that, so long as no event of default occurred and is then continuing, HSBC would release $200,000 of the collateral on each anniversary of the closing date. As of December 31, 2014, HSBC had released $600,000, to reduce the collateral to $400,000.	$	700,000	$	1,120,000
	HSBC
	$6,000,000 Mortgage payable secured by real property Buildings and improvements at 355 South Technology Drive, Central Islip, NY payable in monthly principle installments of $25,000 plus interest. Interest presently accrues at our option, at the variable rate of LIBOR plus 1.75% or HSBC’s prime rate minus 0.50% The loan matures on March 1, 2022.		3,865,508		4,165,508
	Totals		4,565,508		5,285,508
	Less: Current maturities		720,000		720,000
	Long-term debt	$	3,845,508	$	4,565,508
	Future maturities of long-term debt as of December 31, 2014 are as follows:
	2015	$	720,000
	2016		580,000
	2016		300,000
	2018		300,000
	2019		300,000
	Thereafter		2,365,508
		$	4,565,508

Note_9_Earnings_Per_Share

Note 9 - Earnings Per Share	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Note 9 – Earnings per Share
	The calculation of basic and diluted weighted average common shares outstanding is as follows:
		2014		2013
	Weighted average common shares outstanding basic earnings per share		6,129,831		6,071,375
	Effect of potential common share issuance:
	Stock options		---		---
	Weighted average common shares outstanding
	Diluted earnings per share		6,129,831		6,071,375
	Stock options to purchase 259,730 shares of common stock were outstanding and 147,230 were exercisable at December 31, 2014. At December 31, 2014 and 2013 none of the outstanding options were included in the earnings per share calculation as their effect would have been anti-dilutive.

Note_10_Income_Taxes

Note 10 - Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 10 – Income Taxes
	At December 31, 2014, the Company had approximately $27,000 in capital loss carryforwards, $2,808,000 in net operating loss carryforwards, and $696,000 of federal research and development tax credits.
	If not utilized, a portion of the capital loss carryover will expire in 2015, the investment tax credits expire from 2015 through 2029 and the research and development tax credits expire from 2029-2034. Based on the available objective evidence, including the Company’s history of taxable income and the character of that income, management believes it is more likely than not that these components of the Company’s deferred tax assets will be fully utilized. The Company has provided for a partial valuation allowance against its total net deferred tax assets at December 31, 2014 and December 31, 2013 of approximately $475,000 attributable to these components.
	The (benefit) expense for income taxes includes the following:
		2014			2013
	Current:
	Federal	$	240,591		$	----
	State		7,258			----
	Total current tax provision		247,849			----
	Deferred:
	Federal		(1,865,134	)		(1,230,271	)
	State		381,345			(166,136	)
	Total deferred tax provision		(1,483,789	)		(1,396,407	)
	Income tax benefit	$	(1,235,940	)	$	(1,396,407	)
	The tax effects of temporary differences giving rise to significant portions of the net deferred taxes are as follows:
		2014			2013
	Allowance for doubtful accounts	$	16,826		$	45,148
	Inventory capitalization		23,185			36,591
	Depreciation and amortization		(371,669	)		(385,907	)
	Investment tax credits		475,000			600,000
	Research & development tax credits		696,865			683,495
	Compensation costs		375,080			239,876
	Vacation accrual		242,099			274,307
	Accrued loss on legal settlement		1,674,500
	Net operating loss carryforward		1,674,500
	Capital loss carryforward		26,627			1,135,794
	Gross deferred tax asset		4,113,093			2,629,304
	Less valuation allowance		(475,000	)		(475,000	)
	Net deferred tax asset	$	3,638,093		$	2,154,304
	Net current deferred tax asset		2,887,960			1,443,321
	Net long-term deferred tax asset		750,133			710,983
	Net deferred tax asset	$	3,638,093		$	2,154,304
	The reconciliation of the federal statutory income tax rate to our effective tax rate is as follows:
		2014			2013
	Expected provision at federal statutory tax rate (34%)	$	(1,261,218	)	$	(665,288	)
	State taxes, net of federal benefit		7,258			(109,650	)
	Stock-based compensation expense		(307,737	)		(217,648	)
	Deferred gain on sale of building					(301,742	)
	Capital loss carryforward		--			190,517
	Net operating loss carryforward		(37,327	)		--
	Federal research & development credit		(181,782	)		(248,444	)
	Other permanent differences		163,521			(44,152	)
	Impact of New York State taxation change		381,345
	Income tax benefit	$	(1,235,940	)	$	(1,396,407	)

Note_11_Stockholders_Equity

Note 11 - Stockholders' Equity	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	NOTE 11 – Stockholders’ equity
	1989 Non-Qualified Stock Option Plan
	On June 15, 1989, the Company instituted a non-qualified stock option plan (the “Plan”). In connection therewith, 700,000 shares of the Company’s common stock were reserved for issuance pursuant to options that may be granted under the Plan through June 30, 2009. All options granted vest over a four-year period and expire between five to seven years after the date of grant. This 1989 Non-Qualified Stock Option Plan expired in June 2009.
	2001 Non-Qualified Stock Option Plan
	In November 2006, the Company registered a non-qualified stock option plan that the shareholders had approved in July 2001, covering key employees, officers, directors and other persons that may be considered as service providers to the Company. Options were awarded by the Board of Directors or by a committee appointed by the Board. Under the plan, an aggregate of 300,000 shares of Company common stock, $.01 par value, were reserved for issuance or transfer upon the exercise of options which are granted. Unless otherwise provided in the option agreement, options granted under the plan would vest over a four year period commencing one year from the anniversary date of the grant. There were no options granted in 2012. In 2011, 14,000 options were granted to outside directors at an exercise price of $7.90, which vested as to 25% on each of January 15, April 15, July 15 and October 15 of 2011. These options expire ten years after the date of grant. The stock option plan terminated on July 22, 2011.
	2007 Share Incentive Plan
	On December 12, 2007, shareholders approved the Company’s 2007 Share Incentive Plan (“Incentive Plan”), in connection therewith, 750,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the Share Incentive Plan through December 12, 2017. In 2013, 28,087 shares of stock were granted and issued to directors and key employees. In 2014, 42,320 shares of stock were granted and issued to directors and key employees. Also in 2014 options were granted to a key employee for 100,000 shares of the Company’s common stock.
	The purchase price of the common stock under each option plan shall be determined by the Committee, provided, however, that such purchase price shall not be less than the fair market value of the shares on the date such option is granted. The stock options generally expire seven to ten years after the date of grant. The Company recorded stock-based compensation of $515,933 and $461,195 for the years ended December 31, 2014 and 2013, respectively.
	A summary of the stock option activity related to the 1989 and 2001 Stock Option Plans and the 2007 Share Incentive Plan for the period from January 1, 2013 through December 31, 2014 is as follows:
	1989 Non-Qualified Stock Option Plan
			Beginning			Granted			Exercised			Canceled			Ending
			Balance			During			During			During			Balance
			Outstanding			Period			Period			Period			Outstanding			Exercisable
	Year ended December 31, 2013
	Number of shares			41,900			0			6,650			0			35,250			35,250
	Weighted average exercise price
	Per share		$	4.82			0			0			0		$	4.62		$	4.62
	Year ended December 31, 2014
	Number of shares			35,250			0			0			0			35,250			35,250
	Weighted average exercise price
	Per share		$	4.62			0			0			0		$	4.62		$	4.62
	2001 Non-Qualified Stock Option Plan
			Beginning			Granted			Exercised			Canceled			Ending
			Balance			During			During			During			Balance
			Outstanding			Period			Period			Period			Outstanding			Exercisable
	Year ended December 31, 2013
	Number of shares			162,480			0			10,000			0			152,480			127,480
	Weighted average exercise price
	Per share		$	4.35			0			0			0		$	4.4		$	4.35
	Year ended December 31, 2014
	Number of shares			152,480			0			28,000			0			124,480			111,980
	Weighted average exercise price
	Per share		$	4.35			0			0			0		$	4.57		$	4.56
	2007 Share Incentive Plan
			Beginning			Granted			Exercised			Canceled			Ending
			Balance			During			During			During			Balance
			Outstanding			Period			Period			Period			Outstanding			Exercisable
	Year ended December 31, 2013
	Number of shares			200			0			0			200			0			0
	Weighted average exercise price
	Per share		$	11.51
	Year ended December 31, 2014
	Number of shares			0			100,000			0			0			100,000			0
	Weighted average exercise price
	Per share														$	11.17
	The Company has 259,730 of outstanding stock options under the three Plans at December 31, 2014.
	The following table summarizes information about the outstanding and exercisable options at December 31, 2014.
				Options Outstanding												Options Exercisable
							Weighted			Weighted									Weighted
							Average			Average									Average
	Exercise			Number			Remaining			Exercise			Intrinsic			Number			Exercise		Intrinsic
	Price Range			Outstanding			Contractual			Price			Value			Exercisable			Price		Value
	$3.00	-	3.99		34,000			2.95		$	3.65		$	365,160			34,000		$	3.65	$	365,160
	$4.00	-	4.49		15,930			5.04		$	4.25		$	161,530			15,930		$	4.25	$	161,530
	$4.50	-	4.99		100,000			2.78		$	4.62		$	977,000			75,000		$	4.62	$	854,875
	$5.00	-	7.99		9,800			6.04		$	7.9		$	63,602			9,800		$	7.9	$	63,602
	$8.00	-	12		100,000			9.8		$	11.17		$	322,000			0		$	11.17	$	0
	The intrinsic value of the 28,000 options exercised during the year ended December 31, 2014 was $310,520. The intrinsic value of the 16,650 options exercised during the year ended December 31, 2013 was $90,988.
	Restricted Stock Awards
	The following table summarizes restricted stock awards for the year ended December 31, 2014:
						Weighted
						Average Grant
			Shares of			Date Fair
			Restricted Stock			Value
Unvested outstanding at January 1, 2013			16,000		$	10.97
Granted			7,800		$	10.16
Vested			(11,800	)	$	10.43
Forfeited/Cancelled			-
Unvested outstanding at December 31, 2013			12,000		$	10.97
Granted			6,400		$	14.24
Vested			(10,400	)	$	12.98
Forfeited/Cancelled			-
Unvested outstanding at December 31, 2014			8,000		$	10.97
The total fair value of shares of restricted stock awards vested for the years ended December 31, 2014 and 2013 was approximately $135,000 and $123,000 respectively
The fair value of the outstanding restricted stock awards will be recorded as stock compensation expense over the vesting period. As of December 31, 2014 there was $88,000 of unrecognized compensation costs related to restricted stock awards, which is to be recognized over a period of 1.35 years.
Restricted Stock Units
					Weighted
		Shares of			Average Grant
		Restricted			Date Fair
		Stock Units			Value
Unvested outstanding at January 1, 2013			30,575		$	8.29
Granted			133,955		$	11.66
Vested			(20,287	)	$	9.38
Forfeited/Cancelled			-
Unvested outstanding at December 31, 2013			144,243		$	11.26
Granted			-
Vested			(37,925	)	$	10.09
Forfeited/Cancelled			(2,500	)	$	10.71
Unvested outstanding at December 31, 2014			103,319		$	11.71
The total fair value of vested restricted stock units was $383,000 and $190,000 respectively for the years ended December 31, 2014 and 2013.
The fair value of the outstanding restricted stock units will be recorded as stock compensation expense over the vesting period. As of December 31, 2014, there was $1,210,000 of total unrecognized compensation costs related to restricted stock units, which is expected to be recognized over a weighted-average period of 2.19 years.
During the years ended December 31, 2013 and 2012, the Company recorded into selling and general administrative expense approximately $462,000 and $235,000 for the cost of employee and director services received in exchange for equity instruments based on the grant-date fair value of those instruments in accordance with the provisions of ASC 718.
On August 1, 1998, the Company adopted a 401(k) Plan for the benefit of all eligible employees. All employees as of the effective date of the 401(k) Plan became eligible. An employee who became employed after August 1, 1998 would become a participant after three months of continuous service.
Participants may elect to contribute from their compensation any amount up to the maximum deferral allowed by the Internal Revenue Code. Employer contributions are optional. During the years ended December 31, 2014 and 2013, the Company incurred administrative costs totaling $2,800 and $2,380 respectively. No discretionary employer contribution has been made for 2014 and 2013.

Note_12_Defined_Contribution_P

Note 12 - Defined Contribution Plan	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	Note 12 – Defined Contribution Plan (continued)
	$2,800 and $2,380 respectively. No discretionary employer contribution has been made for 2014 and 2013.

Note_13_Significant_Risks_and_

Note 13 - Significant Risks and Uncertainties	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	Note 13 – Significant Risks and Uncertainties
	Cash and Cash Equivalents
	The Company places most of its temporary cash investments with financial institutions, which from time to time may exceed the Federal Deposit Insurance Corporation limit. The amount atrisk at December 31, 2014 and at December 31, 2013 was $10,216,263 and $9,834,765, respectively.
	Sales Concentrations
	Revenue to a single customer in any one year can exceed 10.0% of our total sales. One customer represented 50.2% and 23.7% respectively, of our annual revenues in fiscal years 2014 and 2013. We are not dependent on any single customer, and the loss of any key customer would have to be replaced by others, as we have previously, or our inability to do so may have a material adverse effect on our business and financial condition.
	Export sales to unaffiliated customers represented approximately 20.2% and 27.3% of sales for the years ended December 31, 2014 and 2013, respectively. Export sales in both 2014 and 2013 were primarily to customers in Europe and Asia. All contracts are denominated in U.S. dollars. The Company does not enter into any foreign exchange contracts.

Note_14_Related_Party_Transact

Note 14 - Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 14 – Related Party Transactions
	The Company maintains bank accounts and deposits cash in Community National Bank. Conrad Gunther, a director of the Company, is a Senior Vice President and Senior Loan Officer at Community National Bank. The Company does not pay any fees to Mr. Gunther or Community National Bank in connection with this investment vehicle.

Note_15_Segment_Reporting

Note 15 - Segment Reporting	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	Note 15 – Segment Reporting
	The Company adopted ASC 280, “Segment Reporting.” The Company operates through (2) segments, CVD and SDC. The CVD division is utilized for silicon, silicon germanium, silicon carbide and gallium arsenide processes. SDC is the Company’s ultra-high purity manufacturing division in Saugerties, New York. The accounting policies of CVD and SDC are the same as those described in the summary of significant accounting policies (see Note 2). The Company evaluates performance based on several factors, of which the primary financial measure is earnings before taxes.
	The following table presents certain information regarding the Company’s segments as of December 31, 2014 and for the year then ended:
		CVD			SDC		Eliminations			Consolidated
	Assets	$	44,953,847		$	4,733,926	$	(4,131,301	)	$	45,556,472
	Revenue	$	23,831,036		$	5,580,212	$	(1,420,785	)	$	27,990,463
	Interest Expense		100,829			8,589					109,418
	Depreciation and Amortization		728,995			68,933					797,928
	Capital expenditures		571,240			46,521					617,761
	Pretax (loss)/earnings		(4,877,892	)		1,168,422					(3,709,470	)
	The following table presents certain information regarding the Company’s segments as of December 31, 2013 and for the year then ended:
		CVD			SDC		Eliminations			Consolidated
	Assets	$	39,783,689		$	6,334,352	$	(6,976,402	)	$	39,141,639
	Revenue	$	13,136,083		$	5,155,641	$	(407,797	)	$	17,883,927
	Interest Expense		162,914			824					163,738
	Depreciation and amortization		571,046			75,376					646,422
	Capital expenditures		1,954,621			116,936					2,071,557
	Pretax (loss)/earnings		(2,697,114	)		740,384					(1,956,730	)

Note_16_Commitments_and_Contin

Note 16 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Note 16 - Commitments and Contingencies
	Legal Proceedings
	Effective as of January 29, 2015, CVD Equipment Corporation (the “Company”), Taiwan Glass International Corporation (“Taiwan Glass”) and Capital One, National Association (“Capital One”) entered into an agreement (the “Settlement Agreement”) pursuant to which the parties settled that certain previously disclosed action pending in the United States District Court for the Southern District of New York under Docket No. 10-CV-0573 (the “Action”).
	Pursuant to the terms of the Settlement Agreement, we paid Taiwan Glass the sum of $4,925,000, (said sum being inclusive of interest) and all claims and counterclaims asserted in the Action were settled and dismissed with prejudice. In addition, (a) Taiwan Glass executed limited releases in favor of each of the Company and Capital One concerning the claims asserted by Taiwan Glass in the Action; (b) we executed a limited release in favor of Taiwan Glass concerning the claims asserted by us against Taiwan Glass in the Action; and (c) Capital One executed a limited release in favor of Taiwan Glass concerning the claims asserted by Capital One against Taiwan Glass in the Action.
	In addition, the parties caused to be filed with the Court a Stipulation of Dismissal dismissing the claims and counterclaims asserted against all parties in the Action with prejudice. Taiwan Glass agreed to notify the appropriate authorities in Taiwan that its disputes with the Company and the Company’s directors, officers, employees and agents have been amicably resolved on a business- like basis and the Complaint made by Taiwan Glass in Taiwan is hereby withdrawn.
	On January 19, 2015, CVD Equipment Corporation (the “Company”) received an Arbitration Demand and Complaint which was filed with the American Arbitration Association by Development Specialists, Inc., an Illinois corporation (“DSI”), solely in its capacity as an assignee for the benefit of creditors of CM Manufacturing, Inc. f/k/a Stion Corporation (“Stion”), a Delaware corporation, (collectively the “Plaintiff”).
	In its compliant, the Plaintiff claims, among other things, that the Company breached its agreement with Stion by failing to design, engineer, manufacture and timely deliver a certain custom furnace used in the manufacture of solar panels. The Plaintiff also asserts claims relating to breach of warranty, conversion, misappropriation of trade secrets and a declaration that DSI is not liable under the Company’s Proof of Claim which was previously filed in connection with Stion’s October 2013 Assignment for the Benefit of Creditors. Plaintiff seeks monetary damages of approximately $6.9 million plus interest and attorney’s fees, certain injunctive relief and other unspecified money damages.
	The Company believes that these claims have no merit and intends to vigorously defend its interests in this matter.
	On February 5, 2015, the Company interposed an Answer denying Plaintiff’s claims and raising (15) Affirmative Defenses. Additionally, on March 24, 2015, the Company served and filed a Motion to Dismiss. A decision on this motion is expected shortly. If the Company’s Motion is granted, then the case will be dismissed, otherwise a brief period for discovery will follow and the Arbitration hearing is scheduled to take place the week of August 31, 2015.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation
	The consolidated financial statements include the accounts of CVD Equipment Corporation and its wholly owned subsidiaries. In December 1998, a subsidiary, Stainless Design Concepts, Ltd., was formed as a New York Corporation. In April 1999, this subsidiary was merged into CVD Equipment Corporation. The Company has two wholly owned subsidiaries: CVD Materials Corporation, which provides marketing for our Application Laboratory and FAE Holdings 411519R, LLC, a real estate holding company whose sole asset is its interest in the real estate and building housing our corporate headquarters. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	The Company’s significant estimates are the accounting for certain items such as revenues on long-term contracts recognized on the percentage-of-completion method, depreciation and amortization, valuation allowances for deferred tax assets, impairment considerations of long-lived assets and stock-based compensation.
Revenue Recognition, Percentage-of-Completion Method [Policy Text Block]	Revenue Recognition
	Product and service sales, including those based on time and materials type contracts, are recognized when persuasive evidence of an arrangement exists, product delivery has occurred or services have been rendered, pricing is fixed or determinable, and collection is reasonably assured. Service sales, principally representing repair, maintenance and engineering activities are recognized over the contractual period or as services are rendered.
	Revenues from fixed price contracts are recognized on the percentage of completion method, measured on the basis of incurred costs to estimated total costs for each contract. This “cost to cost” method is used because management considers it to be the best available measure of progress on these contracts.
	Contract costs include all direct material and labor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and depreciation costs.
	Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, and final contract settlements may result in revisions to costs and income and are recognized in the period in which the revisions are determined.
	The asset “Costs and estimated earnings in excess of billings on contracts in progress” represents gross revenues recognized in excess of amounts billed.
	The liability “Billing in excess of costs and estimated earnings on contracts in progress” represents gross amounts billed in excess of revenues recognized.
Inventory, Policy [Policy Text Block]	Inventories
	Inventories are valued at the lower of cost (determined on the first-in, first-out method) or market.
Income Tax, Policy [Policy Text Block]	Income Taxes
	Deferred tax assets and liabilities are determined based on the estimated future tax effects of temporary differences between the financial statements and tax bases of assets and liabilities, as measured by using the future enacted tax rates. Deferred tax expense (benefit) is the result of changes in the deferred tax assets and liabilities. The Company records a valuation allowance against deferred tax assets when it is more likely than not that future tax benefits will not be utilized based on a lack of sufficient positive evidence.
	Investment tax credits are accounted for by the flow-through method, reducing income taxes currently payable and the provision for income taxes in the period the assets giving rise to such credits are placed in service. To the extent such credits are not currently utilized on the Company’s tax return, deferred tax assets, subject to considerations about the need for a valuation allowance, are recognized for the carryforward amount.
	The Company recognizes the tax benefit from an uncertain tax position only if it is more-likely-than-not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The accounting guidance on accounting for uncertainty in income taxes also addresses derecognition, classification, interest and penalties on income taxes, and accounting in interim periods. The Company does not believe it has any uncertain tax positions through the year ending December 31, 2014 which would have a material impact on the Company’s consolidated financial statements.
	The Company and its subsidiaries file combined income tax returns in the U.S. Federal and New York State jurisdiction. In addition, the parent company files standalone tax returns in California, Michigan, Minnesota, New Hampshire and Wisconsin. The Company is no longer subject to U.S. federal and state income tax examinations for tax periods before 2011.
	The Company recognizes interest and penalties accrued related to unrecognized tax benefits, if any, in its income tax provision. The Company had no interest and penalties accrued at December 31, 2014 and 2013.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Long Lived Assets
	Long-lived assets consist primarily of property, plant and equipment. Long-lived assets are reviewed for impairment whenever events or circumstances indicate their carrying value may not be recoverable. When such events or circumstances arise, an estimate of the future undiscounted cash flows produced by the asset, or the appropriate grouping of assets, is compared to the asset’s carrying value to determine if impairment exists pursuant to the requirements of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 360-10-35, “Impairment or Disposal of Long-Lived Assets.” If the asset is determined to be impaired, the impairment loss is measured on the excess of its carrying value over its fair value. Assets to be disposed of are reported at the lower of their carrying value or net realizable value. The Company had no recorded impairment charges in the consolidated statement of operations during each of the years ended December 31, 2014 and 2013.
Property, Plant and Equipment, Policy [Policy Text Block]	Construction in Progress
	Construction in progress consists of amounts expended for renovating the new facility which was purchased on March 15, 2012. Expenditures for maintenance and repairs are charged to operations as incurred; additions, renewals and betterments are capitalized.
Internal Use Software, Policy [Policy Text Block]	Computer Software
	The Company follows ASC 350-40, “Internal Use Software.” This standard requires certain direct development costs associated with internal-use software to be capitalized including external direct costs of material and services and payroll costs for employees devoting time to the software projects. These costs totaled $25,185 and $10,890 for the years ended December 31, 2014 and 2013, respectively, and are included in Other Assets. All computer software is amortized using the straight-line method over its estimated useful life of three to five years. Amortization expense related to computer software totaled $11,386 and $7,433 for the years ended December 31, 2014 and 2013, respectively.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Intangible Assets
	The cost of intangible assets is being amortized on a straight-line basis over their estimated useful lives ranging from 5 to 20 years. Amortization expense recorded by the Company in 2014 and 2013 totaled $20,007 and $6,964, respectively.
Research, Development, and Computer Software, Policy [Policy Text Block]	Research & Development
	Research and development costs are expensed as incurred. With our efforts having been utilized exclusively on customer orders, it has historically been included as part of cost of revenue in the consolidated statements of operations. In 2012 we expanded our laboratory staff and began conducting research and development independently. In 2014 we incurred approximately $1,555,000 of research and development expenses of which $878,000 were independent of external customer orders compared to 2013, when we incurred approximately $1,837,000 of research and development expenses of which approximately $1,013,000 were independent of external customer orders.
Receivables, Policy [Policy Text Block]	Accounts Receivable
	Accounts receivable is presented net of an allowance for doubtful accounts of $24,165 and $107,496 as of December 31, 2014 and 2013, respectively. The allowance is based on historical experience and management’s evaluation of the collectability of accounts receivable. Management believes the allowance is adequate. However, future estimates may fluctuate based on changes in economic and customer conditions. The Company doesn’t require collateral from its customers.
Standard Product Warranty, Policy [Policy Text Block]	Product Warranty
	The Company records warranty costs as incurred and does not provide for possible future costs. Management estimates such costs are immaterial, based on historical experience. However, it is reasonably possible that this estimate may differ in future periods.
Earnings Per Share, Policy [Policy Text Block]	Earnings Per Share
	Basic net earnings per common share is computed by dividing the net income by the weighted average number of shares of common stock outstanding during each period. When applicable, diluted earnings per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be adjusted upon exercise of common stock options and warrants.
	Potential common shares issued are calculated using the treasury stock method, which recognizes the use of proceeds that could be obtained upon the exercise of options and warrants in computing diluted earnings per share. It assumes that any proceeds would be used to purchase common stock at the average market price of the common stock during the period.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
	The Company considers all highly liquid financial instruments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of Credit Risk
	Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company places its cash equivalents with high credit-quality financial institutions and invests its excess cash primarily in money market instruments. The Company has established guidelines relative to credit ratings and maturities that seek to maintain stability and liquidity. The Company sells products and services to various companies across several industries in the ordinary course of business. The Company routinely assesses the financial strength of its customers and maintains allowances for anticipated losses based upon historical experience.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair value of Financial Instruments
	The carrying amounts of financial instruments including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, and customer deposits approximate fair value due to the relatively short term maturity of these instruments. The carrying value of long-term debt approximates fair value based on prevailing borrowing rates currently available for loans with similar terms and maturities.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation
	The Company records stock-based compensation in accordance with the provisions set forth in ASC 718, “Stock Compensation” using the modified prospective method. ASC 718 requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant date fair value of those awards.
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping and Handling
	It is the Company’s policy to include freight charges billed to customers in total revenue. The amount included in revenue was $34,534 and $71,179 for the years ended December 31, 2014 and 2013, respectively. Included in selling and shipping expense is $23,358, and $49,232 for shipping and handling costs for each of the years ended 2014 and 2013, respectively.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Pronouncements
	In July 2013, the FASB issued Accounting Standards Update (“ASU”) 2013-10, Derivatives and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes. The amendments in this Update permit the Fed Funds Effective Swap Rate to be used as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815, in addition to the US Treasury rate and the London Interbank Offered Rate (“LIBOR”). The amendments also remove the restriction on using different benchmark rates for similar hedges. The amendments are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. This ASU is not expected to have a significant impact on the Company’s financial statements.
	In July 2013, the FASB issued ASU 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists. This ASU applies to all entities that have unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. An unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. For nonpublic entities, the amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. Early adoption is permitted. This ASU is not expected to have a significant impact on the Company’s financial statements.
	We believe there is no additional new accounting guidance adopted, but not yet effective that is relevant to the readers of our financial statements. However, there are numerous new proposals under development which, if and when enacted, may have a significant impact on our financial reporting.

Note_3_Contracts_in_Progress_T

Note 3 - Contracts in Progress (Tables)	12 Months Ended
	Dec. 31, 2014
Contractors [Abstract]
Schedule of Cost and Estimated Earnings In Excess of Billings [Table Text Block]		2014			2013
	Costs incurred on contracts in progress	$	4,250,299		$	1,807,628
	Estimated earnings		4,541,377			1,229,038
			8,791,677			3,036,666
	Billings to date		(7,621,523	)		(1,711,587	)
		$	1,170,154		$	1,325,079
		2014			2013
	Included in accompanying balance sheets
	Under the following captions:
	Costs and estimated earnings in excess of billings on contracts in progress	$	2,498,662		$	1,577,969
	Billings in excess of costs and estimated earnings on contracts in progress	$	(1,328,508	)	$	(252,890	)

Note_4_Inventories_Tables

Note 4 - Inventories (Tables)	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]		2014		2013
	Raw materials	$	4,307,913	$	4,058,350
	Work-in-process		419,731		300,460
	Finished goods		114,415		138,539
	Totals	$	4,842,059	$	4,497,349

Note_5_Property_Plant_and_Equi1

Note 5 - Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		2014			2013
	Land	$	2,220,000		$	2,220,000
	Buildings		6,631,039			6,631,039
	Building improvements		5,577,248			5,417,620
	Machinery and equipment		2,333,129			2,329,299
	Furniture and fixtures		712,549			703,999
	Computer equipment		636,819			576,111
	Transportation equipment		65,994			65,994
	Lab equipment		1,564,082			1,560,251
	Totals at cost		19,740,860			19,504,313
	Less: Accumulated depreciation and amortization		(4,715,577	)		(4,012,202	)
		$	15,025,283		$	15,492,111
	Depreciation and amortization expense (1)	$	797,928		$	646,422

Note_6_Intangible_Assets_Table

Note 6 - Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Intangible Assets	Weighted Average Amortization Period		Cost		Accumulated Amortization		Carrying Amount
	Patents & Copyrights		17	$	77,357	$	33,153	$	44,204
	Intellectual Property		15		100,000		88,333		11,667
	Licensing Agreement		5		10,000		10,000		0
	Certifications		3		58,722		58,722		0
	Other		5		21,492		21,492		0
	Totals			$	267,571	$	211,700	$	55,871
	Intangible Assets	Weighted Average Amortization Period		Cost		Accumulated Amortization		Carrying Amount
	Patents & Copyrights		17	$	57,818	$	30,369	$	27,449
	Intellectual Property		15		100,000		83,333		16,667
	Licensing Agreement		5		10,000		10,000		0
	Certifications		3		58,722		58,722		0
	Other		5		21,492		21,492		0
	Totals			$	248,032	$	203,916	$	44,116
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Year Ended
	2015	$	8,084
	2016		8,018
	2017		4,580
	2018		2,915
	2019		2,869
	Thereafter		29,405
	Total	$	55,871

Note_8_Longterm_Debt_Tables

Note 8 - Long-term Debt (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]		2014		2013
	HSBC
	$2,100,000 5 year term loan payable in monthly installments of $35,000 plus interest on the unpaid principal balance which accrues at a fixed rate of 3.045%. This term loan was secured by $1 million, provided that, so long as no event of default occurred and is then continuing, HSBC would release $200,000 of the collateral on each anniversary of the closing date. As of December 31, 2014, HSBC had released $600,000, to reduce the collateral to $400,000.	$	700,000	$	1,120,000
	HSBC
	$6,000,000 Mortgage payable secured by real property Buildings and improvements at 355 South Technology Drive, Central Islip, NY payable in monthly principle installments of $25,000 plus interest. Interest presently accrues at our option, at the variable rate of LIBOR plus 1.75% or HSBC’s prime rate minus 0.50% The loan matures on March 1, 2022.		3,865,508		4,165,508
	Totals		4,565,508		5,285,508
	Less: Current maturities		720,000		720,000
	Long-term debt	$	3,845,508	$	4,565,508
Schedule of Maturities of Long-term Debt [Table Text Block]	2015	$	720,000
	2016		580,000
	2016		300,000
	2018		300,000
	2019		300,000
	Thereafter		2,365,508
		$	4,565,508

Note_9_Earnings_Per_Share_Tabl

Note 9 - Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]		2014		2013
	Weighted average common shares outstanding basic earnings per share		6,129,831		6,071,375
	Effect of potential common share issuance:
	Stock options		---		---
	Weighted average common shares outstanding
	Diluted earnings per share		6,129,831		6,071,375

Note_10_Income_Taxes_Tables

Note 10 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]		2014			2013
	Current:
	Federal	$	240,591		$	----
	State		7,258			----
	Total current tax provision		247,849			----
	Deferred:
	Federal		(1,865,134	)		(1,230,271	)
	State		381,345			(166,136	)
	Total deferred tax provision		(1,483,789	)		(1,396,407	)
	Income tax benefit	$	(1,235,940	)	$	(1,396,407	)
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]		2014			2013
	Allowance for doubtful accounts	$	16,826		$	45,148
	Inventory capitalization		23,185			36,591
	Depreciation and amortization		(371,669	)		(385,907	)
	Investment tax credits		475,000			600,000
	Research & development tax credits		696,865			683,495
	Compensation costs		375,080			239,876
	Vacation accrual		242,099			274,307
	Accrued loss on legal settlement		1,674,500
	Net operating loss carryforward		1,674,500
	Capital loss carryforward		26,627			1,135,794
	Gross deferred tax asset		4,113,093			2,629,304
	Less valuation allowance		(475,000	)		(475,000	)
	Net deferred tax asset	$	3,638,093		$	2,154,304
	Net current deferred tax asset		2,887,960			1,443,321
	Net long-term deferred tax asset		750,133			710,983
	Net deferred tax asset	$	3,638,093		$	2,154,304
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]		2014			2013
	Expected provision at federal statutory tax rate (34%)	$	(1,261,218	)	$	(665,288	)
	State taxes, net of federal benefit		7,258			(109,650	)
	Stock-based compensation expense		(307,737	)		(217,648	)
	Deferred gain on sale of building					(301,742	)
	Capital loss carryforward		--			190,517
	Net operating loss carryforward		(37,327	)		--
	Federal research & development credit		(181,782	)		(248,444	)
	Other permanent differences		163,521			(44,152	)
	Impact of New York State taxation change		381,345
	Income tax benefit	$	(1,235,940	)	$	(1,396,407	)

Note_11_Stockholders_Equity_Ta

Note 11 - Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]			Beginning			Granted			Exercised			Canceled			Ending
			Balance			During			During			During			Balance
			Outstanding			Period			Period			Period			Outstanding			Exercisable
	Year ended December 31, 2013
	Number of shares			41,900			0			6,650			0			35,250			35,250
	Weighted average exercise price
	Per share		$	4.82			0			0			0		$	4.62		$	4.62
	Year ended December 31, 2014
	Number of shares			35,250			0			0			0			35,250			35,250
	Weighted average exercise price
	Per share		$	4.62			0			0			0		$	4.62		$	4.62
			Beginning			Granted			Exercised			Canceled			Ending
			Balance			During			During			During			Balance
			Outstanding			Period			Period			Period			Outstanding			Exercisable
	Year ended December 31, 2013
	Number of shares			162,480			0			10,000			0			152,480			127,480
	Weighted average exercise price
	Per share		$	4.35			0			0			0		$	4.4		$	4.35
	Year ended December 31, 2014
	Number of shares			152,480			0			28,000			0			124,480			111,980
	Weighted average exercise price
	Per share		$	4.35			0			0			0		$	4.57		$	4.56
			Beginning			Granted			Exercised			Canceled			Ending
			Balance			During			During			During			Balance
			Outstanding			Period			Period			Period			Outstanding			Exercisable
	Year ended December 31, 2013
	Number of shares			200			0			0			200			0			0
	Weighted average exercise price
	Per share		$	11.51
	Year ended December 31, 2014
	Number of shares			0			100,000			0			0			100,000			0
	Weighted average exercise price
	Per share														$	11.17
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]				Options Outstanding												Options Exercisable
							Weighted			Weighted									Weighted
							Average			Average									Average
	Exercise			Number			Remaining			Exercise			Intrinsic			Number			Exercise		Intrinsic
	Price Range			Outstanding			Contractual			Price			Value			Exercisable			Price		Value
	$3.00	-	3.99		34,000			2.95		$	3.65		$	365,160			34,000		$	3.65	$	365,160
	$4.00	-	4.49		15,930			5.04		$	4.25		$	161,530			15,930		$	4.25	$	161,530
	$4.50	-	4.99		100,000			2.78		$	4.62		$	977,000			75,000		$	4.62	$	854,875
	$5.00	-	7.99		9,800			6.04		$	7.9		$	63,602			9,800		$	7.9	$	63,602
	$8.00	-	12		100,000			9.8		$	11.17		$	322,000			0		$	11.17	$	0
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]						Weighted
						Average Grant
			Shares of			Date Fair
			Restricted Stock			Value
	Unvested outstanding at January 1, 2013			16,000		$	10.97
	Granted			7,800		$	10.16
	Vested			(11,800	)	$	10.43
	Forfeited/Cancelled			-
	Unvested outstanding at December 31, 2013			12,000		$	10.97
	Granted			6,400		$	14.24
	Vested			(10,400	)	$	12.98
	Forfeited/Cancelled			-
	Unvested outstanding at December 31, 2014			8,000		$	10.97
						Weighted
			Shares of			Average Grant
			Restricted			Date Fair
			Stock Units			Value
	Unvested outstanding at January 1, 2013			30,575		$	8.29
	Granted			133,955		$	11.66
	Vested			(20,287	)	$	9.38
	Forfeited/Cancelled			-
	Unvested outstanding at December 31, 2013			144,243		$	11.26
	Granted			-
	Vested			(37,925	)	$	10.09
	Forfeited/Cancelled			(2,500	)	$	10.71
	Unvested outstanding at December 31, 2014			103,319		$	11.71

Note_15_Segment_Reporting_Tabl

Note 15 - Segment Reporting (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]		CVD			SDC		Eliminations			Consolidated
	Assets	$	44,953,847		$	4,733,926	$	(4,131,301	)	$	45,556,472
	Revenue	$	23,831,036		$	5,580,212	$	(1,420,785	)	$	27,990,463
	Interest Expense		100,829			8,589					109,418
	Depreciation and Amortization		728,995			68,933					797,928
	Capital expenditures		571,240			46,521					617,761
	Pretax (loss)/earnings		(4,877,892	)		1,168,422					(3,709,470	)
		CVD			SDC		Eliminations			Consolidated
	Assets	$	39,783,689		$	6,334,352	$	(6,976,402	)	$	39,141,639
	Revenue	$	13,136,083		$	5,155,641	$	(407,797	)	$	17,883,927
	Interest Expense		162,914			824					163,738
	Depreciation and amortization		571,046			75,376					646,422
	Capital expenditures		1,954,621			116,936					2,071,557
	Pretax (loss)/earnings		(2,697,114	)		740,384					(1,956,730	)

Note_2_Summary_of_Significant_1

Note 2 - Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	$0	$0
Impairment of Long-Lived Assets Held-for-use	0	0
Capitalized Computer Software, Net	25,185	10,890
Capitalized Computer Software, Amortization	11,386	7,433
Amortization of Intangible Assets	20,007	6,964
Research and Development Expense	877,788	1,013,157
Allowance for Doubtful Accounts Receivable, Current	24,165	107,496
Freight Costs	34,534	71,179
Shipping, Handling and Transportation Costs	23,358	49,232
Software and Software Development Costs [Member] | Minimum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Software and Software Development Costs [Member] | Maximum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Minimum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	5 years
Maximum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years
Including External Customer Orders [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Research and Development Expense	$1,555,000	$1,837,000

Note_3_Contracts_in_Progress_D

Note 3 - Contracts in Progress (Details) - Costs, Estimated Earnings, and Billings on Uncompleted Contracts (USD $)	Dec. 31, 2014	Dec. 31, 2013
Costs, Estimated Earnings, and Billings on Uncompleted Contracts [Abstract]
Costs incurred on contracts in progress	$4,250,299	$1,807,628
Estimated earnings	4,541,377	1,229,038
	8,791,677	3,036,666
Billings to date	-7,621,523	-1,711,587
	1,170,154	1,325,079
Costs and estimated earnings in excess of billings on contracts in progress	2,498,662	1,577,969
Billings in excess of costs and estimated earnings on contracts in progress	($1,328,508)	($252,890)

Note_4_Inventories_Details_Inv

Note 4 - Inventories (Details) - Inventories (USD $)	Dec. 31, 2014	Dec. 31, 2013
Inventories [Abstract]
Raw materials	$4,307,913	$4,058,350
Work-in-process	419,731	300,460
Finished goods	114,415	138,539
Totals	$4,842,059	$4,497,349

Note_5_Property_Plant_and_Equi2

Note 5 - Property, Plant and Equipment (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Abstract]
Amortization	$20,007	$20,434

Note_5_Property_Plant_and_Equi3

Note 5 - Property, Plant and Equipment (Details) - Major Classes of Property, Plant and Equipment (USD $)	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$19,740,860		$19,504,313
Less: Accumulated depreciation and amortization	-4,715,577		-4,012,202
	15,025,283		15,492,111
Depreciation and amortization expense (1)	797,928	[1]	646,422	[1]
Land [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,220,000		2,220,000
Building [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,631,039		6,631,039
Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	5,577,248		5,417,620
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,333,129		2,329,299
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	712,549		703,999
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	636,819		576,111
Transportation Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	65,994		65,994
Lab Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$1,564,082		$1,560,251
[1]	Includes amortization expense of $20,007 and $20,434 for the years ending December 31, 2014 and 2013, respectively. Such amortization expense relates to other capitalized and intangible assets.

Note_6_Intangible_Assets_Detai

Note 6 - Intangible Assets (Details) - Intangible Assets (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Cost	$267,571	$248,032
Accumulated Amortization	211,700	203,916
Carrying Amount	55,871	44,116
Patents and Copyrights [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	17 years	17 years
Cost	77,357	57,818
Accumulated Amortization	33,153	30,369
Carrying Amount	44,204	27,449
Intellectual Property [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	15 years	15 years
Cost	100,000	100,000
Accumulated Amortization	88,333	83,333
Carrying Amount	11,667	16,667
Licensing Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	5 years	5 years
Cost	10,000	10,000
Accumulated Amortization	10,000	10,000
Carrying Amount	0	0
Certifications [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	3 years	3 years
Cost	58,722	58,722
Accumulated Amortization	58,722	58,722
Carrying Amount	0	0
Other Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Amortization Period	5 years	5 years
Cost	21,492	21,492
Accumulated Amortization	21,492	21,492
Carrying Amount	$0	$0

Note_6_Intangible_Assets_Detai1

Note 6 - Intangible Assets (Details) - Estimated Amortization Expense Related to Intangible Assets (USD $)	Dec. 31, 2014
Estimated Amortization Expense Related to Intangible Assets [Abstract]
2015	$8,084
2016	8,018
2017	4,580
2018	2,915
2019	2,869
Thereafter	29,405
Total	$55,871

Note_7_Financing_Arrangements_

Note 7 - Financing Arrangements (Details) (USD $)	0 Months Ended	12 Months Ended
	Aug. 05, 2011	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2012
Note 7 - Financing Arrangements (Details) [Line Items]
Restricted Cash and Cash Equivalents		$400,000
Long-term Debt		4,565,508	5,285,508
HSBC Bank [Member] | Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Note 7 - Financing Arrangements (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.75%
HSBC Bank [Member] | Revolving Credit Facility [Member] | Prime Rate [Member]
Note 7 - Financing Arrangements (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
HSBC Bank [Member] | Revolving Credit Facility [Member]
Note 7 - Financing Arrangements (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	7,000,000
HSBC Bank [Member] | Five-Year Term Loan [Member]
Note 7 - Financing Arrangements (Details) [Line Items]
Debt Instrument, Term	5 years
Debt Instrument, Face Amount	2,100,000
Debt Instrument, Collateral Amount	1,000,000
Debt Instrument, Collateral Release Amount	200,000
Debt Instrument, Periodic Payment		35,000
Loans Payable to Bank		700,000	1,120,000
HSBC Bank [Member] | HSBC Bank Mortgage Loan [Member] | London Interbank Offered Rate (LIBOR) [Member]
Note 7 - Financing Arrangements (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate		1.75%
HSBC Bank [Member] | HSBC Bank Mortgage Loan [Member]
Note 7 - Financing Arrangements (Details) [Line Items]
Debt Instrument, Face Amount				6,000,000
Debt Instrument, Interest Rate, Stated Percentage		1.91%	1.92%
Long-term Debt		3,865,508
HSBC Bank [Member]
Note 7 - Financing Arrangements (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	9,100,000

Note_8_Longterm_Debt_Details_L

Note 8 - Long-term Debt (Details) - Long-term Debt (USD $)	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Totals	$4,565,508	$5,285,508
Less: Current maturities	720,000	720,000
Long-term debt	3,845,508	4,565,508
Five-Year Term Loan [Member]
Debt Instrument [Line Items]
Secured debt	700,000	1,120,000
HSBC Bank Mortgage Loan [Member]
Debt Instrument [Line Items]
Secured debt	$3,865,508	$4,165,508

Note_8_Longterm_Debt_Details_L1

Note 8 - Long-term Debt (Details) - Long-term Debt (Parentheticals) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Five-Year Term Loan [Member]
Debt Instrument [Line Items]
DP5bt instrumP5nt, facP5 amount	$2,100,000	$2,100,000
DP5bt instrumP5nt, term	5 years	5 years
Monthly installmP5nts	35,000	35,000
IntP5rP5st rate	3.05%	3.05%
CollatP5ral	400,000	600,000
HSBC Bank Mortgage Loan [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument [Line Items]
Variable rate	1.75%	1.75%
HSBC Bank Mortgage Loan [Member] | Prime Rate [Member]
Debt Instrument [Line Items]
Variable rate	0.50%	0.50%
HSBC Bank Mortgage Loan [Member]
Debt Instrument [Line Items]
DP5bt instrumP5nt, facP5 amount	6,000,000	6,000,000
Monthly installmP5nts	$25,000	$25,000

Note_8_Longterm_Debt_Details_F

Note 8 - Long-term Debt (Details) - Future Maturities of Long-term Debt (USD $)	Dec. 31, 2014	Dec. 31, 2013
Future Maturities of Long-term Debt [Abstract]
2015	$720,000
2016	580,000
2016	300,000
2018	300,000
2019	300,000
Thereafter	2,365,508
	$4,565,508	$5,285,508

Note_9_Earnings_Per_Share_Deta

Note 9 - Earnings Per Share (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Earnings Per Share [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	259,730
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	147,230
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	0	0

Note_9_Earnings_Per_Share_Deta1

Note 9 - Earnings Per Share (Details) - Calculation of Basic and Diluted Weighted Average Common Shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Calculation of Basic and Diluted Weighted Average Common Shares [Abstract]
Weighted average common shares outstanding basic earnings per share	6,129,831	6,071,375
Effect of potential common share issuance:
Stock options	0	0
Diluted earnings per share	6,129,831	6,071,375

Note_10_Income_Taxes_Details

Note 10 - Income Taxes (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Note 10 - Income Taxes (Details) [Line Items]
Operating Loss Carryforwards		$2,808,000
Deferred Tax Assets, Valuation Allowance	475,000	475,000
Capital Loss Carryforward [Member]
Note 10 - Income Taxes (Details) [Line Items]
Tax Credit Carryforward, Amount		27,000
Research Tax Credit Carryforward [Member]
Note 10 - Income Taxes (Details) [Line Items]
Tax Credit Carryforward, Amount		$696,000

Note_10_Income_Taxes_Details_C

Note 10 - Income Taxes (Details) - Components of Income Taxes (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Current:
Federal	$240,591	$0
State	7,258	0
Total current tax provision	247,849	0
Deferred:
Federal	-1,865,134	-1,230,271
State	381,345	-166,136
Total deferred tax provision	-1,483,789	-1,396,407
Income tax benefit	($1,235,940)	($1,396,407)

Note_10_Income_Taxes_Details_D

Note 10 - Income Taxes (Details) - Deferred Tax Assets and Liabilities (USD $)	Dec. 31, 2014	Dec. 31, 2013
Deferred Tax Assets and Liabilities [Abstract]
Allowance for doubtful accounts	$16,826	$45,148
Inventory capitalization	23,185	36,591
Depreciation and amortization	-371,669	-385,907
Investment tax credits	475,000	600,000
Research & development tax credits	696,865	683,495
Compensation costs	375,080	239,876
Vacation accrual	242,099	274,307
Accrued loss on legal settlement	1,674,500
Net operating loss carryforward	1,674,500
Capital loss carryforward	26,627	1,135,794
Gross deferred tax asset	4,113,093	2,629,304
Less valuation allowance	-475,000	-475,000
Net deferred tax asset	3,638,093	2,154,304
Net current deferred tax asset	2,887,960	1,443,321
Net long-term deferred tax asset	750,133	710,983
Net deferred tax asset	$3,638,093	$2,154,304

Note_10_Income_Taxes_Details_E

Note 10 - Income Taxes (Details) - Effective Income Tax Rate Reconcilliation (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Effective Income Tax Rate Reconcilliation [Abstract]
Expected provision at federal statutory tax rate (34%)	($1,261,218)	($665,288)
State taxes, net of federal benefit	7,258	-109,650
Stock-based compensation expense	-307,737	-217,648
Deferred gain on sale of building		-301,742
Capital loss carryforward		190,517
Net operating loss carryforward	-37,327
Federal research & development credit	-181,782	-248,444
Other permanent differences	163,521	-44,152
Impact of New York State taxation change	381,345
Income tax benefit	($1,235,940)	($1,396,407)

Note_10_Income_Taxes_Details_E1

Note 10 - Income Taxes (Details) - Effective Income Tax Rate Reconcilliation (Parentheticals)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Effective Income Tax Rate Reconcilliation [Abstract]
Federal statutory tax rate	34.00%	34.00%

Note_11_Stockholders_Equity_De

Note 11 - Stockholders' Equity (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Jun. 15, 1989	Nov. 30, 2006	Dec. 12, 2007
Note 11 - Stockholders' Equity (Details) [Line Items]
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$0.01	$0.01
Allocated Share-based Compensation Expense		$515,933	$461,195
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)	259,730
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)	28,000	16,650
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	310,520	90,988
Selling, General and Administrative Expenses [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Allocated Share-based Compensation Expense		462,000	235,000
Restricted Stock [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	135,000	123,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	88,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 127 days
Restricted Stock Units (RSUs) [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	383,000	190,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$1,210,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	2 years 69 days
Minimum [Member] | The 1989 Non-Qualified Stock Option Plan [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	5 years
Minimum [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	7 years
Maximum [Member] | The 1989 Non-Qualified Stock Option Plan [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	7 years
Maximum [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Director [Member] | The 2001 Non-Qualified Stock Option Plan [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)				14,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)				$7.90
Directors and Key Employees [Member] | The 2007 Share Incentive Plan [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	42,320	28,087
Key Employee [Member] | The 2007 Share Incentive Plan [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	100,000
The 1989 Non-Qualified Stock Option Plan [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)					700,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	4 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	0	0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)	$0	$0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)	35,250	35,250	41,900
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)	0	6,650
The 2001 Non-Qualified Stock Option Plan [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)						300,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	4 years
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period				10 years
Common Stock, Par or Stated Value Per Share (in Dollars per share)						$0.01
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	0	0	0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)	$0	$0
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights				25%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)	124,480	152,480	162,480
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)	28,000	10,000
The 2007 Share Incentive Plan [Member]
Note 11 - Stockholders' Equity (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)							750,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	100,000	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)	100,000	0	200
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares)	0	0

Note_11_Stockholders_Equity_De1

Note 11 - Stockholders' Equity (Details) - Stock Option Plan (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 11 - Stockholders' Equity (Details) - Stock Option Plan [Line Items]
Number of shares, exercised during period	28,000	16,650
Number of shares, ending balance outstanding	259,730
Number of shares, exercisable	147,230
The 1989 Non-Qualified Stock Option Plan [Member]
Note 11 - Stockholders' Equity (Details) - Stock Option Plan [Line Items]
Number of shares, beginning balance outstanding	35,250	41,900
Number of shares, granted during period	0	0
Number of shares, exercised during period	0	6,650
Number of shares, canceled during period	0	0
Number of shares, ending balance outstanding	35,250	35,250
Number of shares, exercisable	35,250	35,250
Weighted average exercise price per share, beginning balance outstanding (in Dollars per share)	$4.62	$4.82
Weighted average exercise price per share, granted during period (in Dollars per share)	$0	$0
Weighted average exercise price per share, exercised during period (in Dollars per share)	$0	$0
Weighted average exercise price per share, canceled during period (in Dollars per share)	$0	$0
Weighted average exercise price per share, ending balance outstanding (in Dollars per share)	$4.62	$4.62
Weighted average exercise price per share, exercisable (in Dollars per share)	$4.62	$4.62
The 2001 Non-Qualified Stock Option Plan [Member]
Note 11 - Stockholders' Equity (Details) - Stock Option Plan [Line Items]
Number of shares, beginning balance outstanding	152,480	162,480
Number of shares, granted during period	0	0	0
Number of shares, exercised during period	28,000	10,000
Number of shares, canceled during period	0	0
Number of shares, ending balance outstanding	124,480	152,480	162,480
Number of shares, exercisable	111,980	127,480
Weighted average exercise price per share, beginning balance outstanding (in Dollars per share)	$4.40	$4.35
Weighted average exercise price per share, granted during period (in Dollars per share)	$0	$0
Weighted average exercise price per share, exercised during period (in Dollars per share)	$0	$0
Weighted average exercise price per share, canceled during period (in Dollars per share)	$0	$0
Weighted average exercise price per share, ending balance outstanding (in Dollars per share)	$4.57	$4.40	$4.35
Weighted average exercise price per share, exercisable (in Dollars per share)	$4.56	$4.35
The 2007 Share Incentive Plan [Member]
Note 11 - Stockholders' Equity (Details) - Stock Option Plan [Line Items]
Number of shares, beginning balance outstanding	0	200
Number of shares, granted during period	100,000	0
Number of shares, exercised during period	0	0
Number of shares, canceled during period	0	200
Number of shares, ending balance outstanding	100,000	0
Number of shares, exercisable	0	0
Weighted average exercise price per share, beginning balance outstanding (in Dollars per share)		$11.51
Weighted average exercise price per share, ending balance outstanding (in Dollars per share)	$11.17

Note_11_Stockholders_Equity_De2

Note 11 - Stockholders' Equity (Details) - Outstanding and Exercisable Options (USD $)	12 Months Ended
	Dec. 31, 2014
Exercise Price Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	$3
Exercise price range, upper limit	$3.99
Options outstanding, number outstanding (in Shares)	34,000
Options outstanding, weighted average remaining contractual	2 years 346 days
Options outstanding, weighted average exercise price	$3.65
Options outstanding, intrinsic value (in Dollars)	$365,160
Options exercisable, numnber exercisable (in Shares)	34,000
Options exercisable, weighted average exercise price	$3.65
Options exercisable, intrinsic value (in Dollars)	365,160
Exercise Price Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	$4
Exercise price range, upper limit	$4.49
Options outstanding, number outstanding (in Shares)	15,930
Options outstanding, weighted average remaining contractual	5 years 14 days
Options outstanding, weighted average exercise price	$4.25
Options outstanding, intrinsic value (in Dollars)	161,530
Options exercisable, numnber exercisable (in Shares)	15,930
Options exercisable, weighted average exercise price	$4.25
Options exercisable, intrinsic value (in Dollars)	161,530
Exercise Price Range 3 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	$4.50
Exercise price range, upper limit	$4.99
Options outstanding, number outstanding (in Shares)	100,000
Options outstanding, weighted average remaining contractual	2 years 284 days
Options outstanding, weighted average exercise price	$4.62
Options outstanding, intrinsic value (in Dollars)	977,000
Options exercisable, numnber exercisable (in Shares)	75,000
Options exercisable, weighted average exercise price	$4.62
Options exercisable, intrinsic value (in Dollars)	854,875
Exercise Price Range 4 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	$5
Exercise price range, upper limit	$7.99
Options outstanding, number outstanding (in Shares)	9,800
Options outstanding, weighted average remaining contractual	6 years 14 days
Options outstanding, weighted average exercise price	$7.90
Options outstanding, intrinsic value (in Dollars)	63,602
Options exercisable, numnber exercisable (in Shares)	9,800
Options exercisable, weighted average exercise price	$7.90
Options exercisable, intrinsic value (in Dollars)	63,602
Exercise Price Range 5 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	$8
Exercise price range, upper limit	$12
Options outstanding, number outstanding (in Shares)	100,000
Options outstanding, weighted average remaining contractual	9 years 292 days
Options outstanding, weighted average exercise price	$11.17
Options outstanding, intrinsic value (in Dollars)	322,000
Options exercisable, numnber exercisable (in Shares)	0
Options exercisable, weighted average exercise price	$11.17
Options exercisable, intrinsic value (in Dollars)	$0

Note_11_Stockholders_Equity_De3

Note 11 - Stockholders' Equity (Details) - Restricted Stock and Restricted Stock Units Activity (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Restricted Stock [Member]
Note 11 - Stockholders' Equity (Details) - Restricted Stock and Restricted Stock Units Activity [Line Items]
Unvested outstanding	8,000	12,000	16,000
Unvested outstanding, weighted average grant date fair value	$10.97	$10.97	$10.97
Granted	6,400	7,800
Granted, weighted average grant date fair value	$14.24	$10.16
Vested	-10,400	-11,800
Vested, weighted average grant date fair value	$12.98	$10.43
Restricted Stock Units (RSUs) [Member]
Note 11 - Stockholders' Equity (Details) - Restricted Stock and Restricted Stock Units Activity [Line Items]
Unvested outstanding	103,319	144,243	30,575
Unvested outstanding, weighted average grant date fair value	$11.71	$11.26	$8.29
Granted		133,955
Granted, weighted average grant date fair value		$11.66
Vested	-37,925	-20,287
Vested, weighted average grant date fair value	$10.09	$9.38
Forfeited/Cancelled	-2,500
Forfeited/Cancelled, weighted average grant date fair value	$10.71

Note_12_Defined_Contribution_P1

Note 12 - Defined Contribution Plan (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]
Defined Contribution Plan, Administrative Expenses	$2,800	$2,380
Defined Contribution Plan, Employer Discretionary Contribution Amount	$0	$0

Note_13_Significant_Risks_and_1

Note 13 - Significant Risks and Uncertainties (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note 13 - Significant Risks and Uncertainties (Details) [Line Items]
Cash, Uninsured Amount (in Dollars)	$10,216,263	$9,834,765
Number of Major Customers	1	1
Export Sales to Unaffiliated Customers as Percentage of Total Sales	20.20%	27.30%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Note 13 - Significant Risks and Uncertainties (Details) [Line Items]
Concentration Risk, Percentage	50.20%	23.70%

Note_15_Segment_Reporting_Deta

Note 15 - Segment Reporting (Details)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Number of Operating Segments	2

Note_15_Segment_Reporting_Deta1

Note 15 - Segment Reporting (Details) - Segment Information (USD $)	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Segment Reporting Information [Line Items]
Assets	$45,556,472		$39,141,639
Revenue	27,990,463		17,883,927
Interest Expense	109,418		163,738
Depreciation and Amortization	797,928	[1]	646,422	[1]
Capital expenditures	617,761		2,071,557
Pretax (loss)/earnings	-3,709,470		-1,956,730
CVD [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Assets	44,953,847		39,783,689
Revenue	23,831,036		13,136,083
Interest Expense	100,829		162,914
Depreciation and Amortization	728,995		571,046
Capital expenditures	571,240		1,954,621
Pretax (loss)/earnings	-4,877,892		-2,697,114
SDC [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Assets	4,733,926		6,334,352
Revenue	5,580,212		5,155,641
Interest Expense	8,589		824
Depreciation and Amortization	68,933		75,376
Capital expenditures	46,521		116,936
Pretax (loss)/earnings	1,168,422		740,384
Intersegment Eliminations [Member]
Segment Reporting Information [Line Items]
Assets	-4,131,301		-6,976,402
Revenue	($1,420,785)		($407,797)
[1]	Includes amortization expense of $20,007 and $20,434 for the years ending December 31, 2014 and 2013, respectively. Such amortization expense relates to other capitalized and intangible assets.

Note_16_Commitments_and_Contin1

Note 16 - Commitments and Contingencies (Details) (Subsequent Event [Member], USD $)	0 Months Ended
	Jan. 19, 2015	Jan. 29, 2015
Note 16 - Commitments and Contingencies (Details) [Line Items]
Payments for Legal Settlements		$4,925,000
Pending Litigation [Member]
Note 16 - Commitments and Contingencies (Details) [Line Items]
Loss Contingency, Damages Sought, Value	$6,900,000